C
Corvus Pharmaceuticals, Inc. (CRVS)
NGM – Real vaqt narxi. Valyuta: USD
15.97
+0.16 (1.01%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NGM – Real vaqt narxi. Valyuta: USD
15.97
+0.16 (1.01%)
Yopilishda: May 12, 2026, 4:00 PM EDT
This stock has a consensus price target of $25.69 based on the ratings of 9 analysts. The high is $42.00 and the low is $3.50.
| Maqsad | Min. maqsadli narx | O‘rtacha maqsadli narx | Maks. maqsadli narx |
|---|---|---|---|
| Narx | $ 3.5 | $ 25.69 | $ 42 |
| O’zgarish | -77.86% | 62.49% | 165.65% |
| Sana | O‘sish/pasayish potensiali | Tahlilchi firmasi | Maqsadli narx | Reyting o‘zgarishi | Reyting |
|---|---|---|---|---|---|
| 2026-04-17 | 150% | Goldman Sachs | $40 | Initiates Coverage On | Buy |
| 2026-03-13 | 106.25% | Oppenheimer | $32 → $33 | Reiterates | Outperform |
| 2026-01-22 | 162.5% | Jefferies | $13 → $42 | Maintains | Buy |
| 2026-01-21 | 100% | Oppenheimer | $15 → $32 | Maintains | Outperform |
| 2026-01-21 | 75% | Barclays | $16 → $28 | Maintains | Overweight |